Forest Laboratories, Inc. today announced the launch of the STRIDE patient support program to help those prescribed TudorzaA PressairA or DalirespA by answering questions they may have about their chronic obstructive pulmonary disease treatment.
http://ift.tt/1piNvw0
http://ift.tt/1piNvw0
No comments:
Post a Comment